SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-013970
Filing Date
2020-11-18
Accepted
2020-11-18 16:06:58
Documents
13
Period of Report
2020-11-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20201112x8k.htm   iXBRL 8-K 48416
2 EX-3.1 chrs-20201112xex3d1.htm EX-3.1 258177
  Complete submission text file 0001558370-20-013970.txt   470382

Data Files

Seq Description Document Type Size
3 EX-101.SCH chrs-20201112.xsd EX-101.SCH 2846
4 EX-101.LAB chrs-20201112_lab.xml EX-101.LAB 16817
5 EX-101.PRE chrs-20201112_pre.xml EX-101.PRE 11888
6 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20201112x8k_htm.xml XML 5141
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 201324978
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences